Pfizer and biontech sign agreement for additional supply to turkey of 60 million doses of their covid-19 vaccine

Istanbul, turkey and mainz, germany, may 20, 2021 (globe newswire) — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the biontech europe gmbh has entered into an agreement with turkey's ministry of health to supply 60 million additional doses of the companies' covid-19 vaccine, with an option for an additional 30 million doses. on december 25, 2020, the two companies announced an initial agreement to provide 30 million doses of the pfizer-biontech vaccine to turkey. this second supply agreement brings the total number of doses to be supplied to turkey to up to 120 million, all of which will be delivered in 2021.
BNTX Ratings Summary
BNTX Quant Ranking